Skip Navigation

Link to  the National Institutes of Health  
The Science of Drug Abuse and Addiction from the National Institute on Drug Abuse Archives of the National Institute on Drug Abuse web site
Go to the Home page

Home > Publications > Research Monographs >    

Phencyclidine: An Update

NIDA Research Monograph, Number 64 [Printed in 1986]

Get Adobe Reader

This monograph is not available by chapter. The Table of Contents (below) is shown to assist in locating information prior to downloading the monograph.

Download Monograph64.pdf - Phencyclidine: An Update (2.3 MB)

Table of Contents



Characterization of Phencyclidine and Sigma Receptor-Binding Sites in Brain-----1
Andrew L. GundZach, Brian L. Lurgent, and Solomon H. Snyder

Further Evidence of Phencyclidine/Sigma Opioid Receptor Commonality-----14
Ratna Sircar and Stephen R. Zukin

Isolation and Identification of an Endogenous Ligand for the Phencyclidine Receptor-----24
Debora A. DiMaggio, Patricia C. Contreras, Remi Quirion, and Thomas L. O' Donohue

ic Phencyclidine (PCP) Selectively Blocks Certain Presynapt Potassium Channels-----37
Mordecai P. Blaustein, Dieter K. Bartschat, and Roger G. Sorensen

Involvement of Dopaminergic, Cholinergic, and Glutamatergic Mechanisms in the Actions of Phencyclidine-Like Drugs-----52
Kenneth M. Johnson and Lawrence D. Snell

Anticonvulsant Properties of Phencyclidine and Ketamine-----67
Gary G. Buterbaugh and Hillary B. Michelson

Agonistic and Antagonistic Effects of PCP-Derivatives and Sigma Opioids in PCP Behavioral and Receptor Assays-----80
Patricia C. Contreras, Remi Quirion, and Thomas L. O'Donohue

Electroencephalographic (EEG), Psychopharmacological, and Receptor-Binding Profiles of 'Phencyclinoids'-----94
Antonia Mattia, Arthur P. Leccese, Karen L. Marquis, Esam E. El-Fakahany and J. Edward Moreton

Modulation of Phencyclidine (PCP) Pharmacokinetics With PCP-Specific Fab Fragments-----112
S. Michael Owens and Michael Mayersohn

Psychopharmacology of Phencyclidine-----127
Joe Marwah and David K. Pitts

Discriminative Stimulus Properties of PCP Mimetics-----134
Ronald G. Browne

Clinical Implications of Behavioral Pharmacology Research on Phencyclidine-----148
Robert L. Balster

Phencyclidine: Changing Abuse Patterns-----163
Raquel Crider

PCP and Crime: Just Another Illicit Drug?-----174
Eric D. Wish

Neuropsychological Assessment of Phencyclidine Abusers-----190
James E. Lewis and Robert B. Hordan

Phencyclidine Intoxication-----209
Margaret M. McCarron

Diagnosis and Treatment of Chronic Phencyclidine (PCP) Abuse-----218
David A. Gorelick, Jeffrey N. Wilkins, and Carl Wong

Legal Issues Associated With PCP Abuse--The Role of the Forensic Expert-----229
Steven E. Serner and Richard S. Burns

The Long-Term Effects on Neurodevelopment in Infants Exposed Prenatally to PCP-----237
Judy Howard, Vickie Kropenske, and Rachelle Tyler

Clinical Observations in the Treatment of Adolescent and Young Adult PCP Abusers-----252
David H. Fram and Nancy Stone

List of NIDA Research Monographs-----261

Archive Home | Accessibility | Privacy | FOIA (NIH) | Current NIDA Home Page
National Institutes of Health logo_Department of Health and Human Services Logo The National Institute on Drug Abuse (NIDA) is part of the National Institutes of Health (NIH) , a component of the U.S. Department of Health and Human Services. Questions? See our Contact Information. . The U.S. government's official web portal